EGFR and cardiomyopathy: The results of KEGG enrichment analysis (Figure 10D) revealed that there was a notable enrichment of pathways associated with EGFR tyrosine kinase inhibitor resistance, parathyroid hormone synthesis, secretion and action, adrenergic signaling in cardiomyocytes, and tryptophan metabolism, which may contribute to cardiomyopathy.